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Background. RNA interference (RNAi), mediated by small interfering RNA (siRNA), is an effective method used to silence gene
expression at the post-transcriptional level. Upon introduction into target cells, siRNAs incorporate into the RNA-induced
silencing complex (RISC). The antisense strand of the siRNA duplex then ‘‘guides’’ the RISC to the homologous mRNA, leading
to target degradation and gene silencing. In recent years, various vector-based siRNA expression systems have been
developed which utilize opposing polymerase III promoters to independently drive expression of the sense and antisense
strands of the siRNA duplex from the same template. Principal Findings. We show here the use of a ligase chain reaction
(LCR) to develop a new vector system called pInv-H1 in which a DNA sequence encoding a specific siRNA is placed between
two inverted minimal human H1 promoters (,100 bp each). Expression of functional siRNAs from this construct has led to
efficient silencing of both reporter and endogenous genes. Furthermore, the inverted H1 promoter-siRNA expression cassette
was used to generate a retrovirus vector capable of transducing and silencing expression of the targeted protein by.80% in
target cells. Conclusions. The unique design of this construct allows for the efficient exchange of siRNA sequences by the
directional cloning of short oligonucleotides via asymmetric restriction sites. This provides a convenient way to test the
functionality of different siRNA sequences. Delivery of the siRNA cassette by retroviral transduction suggests that a single copy
of the siRNA expression cassette efficiently knocks down gene expression at the protein level. We note that this vector system
can potentially be used to generate a random siRNA library. The flexibility of the ligase chain reaction suggests that additional
control elements can easily be introduced into this siRNA expression cassette.
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INTRODUCTION
The use of RNA interference as a method of gene silencing has
been an effective tool in analyzing gene function. First discovered
in Caenorhabditis elegans [1], the phenomenon of RNAi has also been
observed in Drosophila [2,3], Trypanosoma [4], and other organisms.
RNAi also occurs in plants by a process called post-transcriptional
gene silencing (PTGS) [5,6] and in fungi by a process called
quelling [7]. In mammalian cells, dsRNA longer than 30 nucleo-
tides (nt) induces an interferon response [8] that triggers non-
specific degradation of mRNA. As a result, the application of
RNAi in mammalian cells has been limited. However, after
Elbashir et al. showed that base-paired 21-22 nt siRNAs with 39
overhanging ends were capable of mediating sequence-specific
degradation of mRNA in Drosophila embryo lysates [9], they
determined that siRNAs also mediated sequence-specific gene
silencing in mammals [8] without induction of the interferon
response. Thus with the identification of siRNAs as the mediators
of RNAi, many siRNA expression systems have been developed
for efficient gene silencing.
Plasmid-based expression systems that use type III RNA
polymerase III (pol III) promoters such as the U6 promoter and
the H1 promoter have been developed by several groups and used
to express functional siRNAs [10–14]. In the type I and type II
classes of pol III promoters, the promoter elements are located
entirely within the transcribed region [15]. In the case of the type
III class of promoters, transcription is driven by cis-acting elements
that are found only in the 59 region flanking the gene to be
transcribed. It has been demonstrated that deletion of sequences
that are downstream of the transcriptional start site in the mouse
and human U6 promoters has no effect on transcription levels
[15]. Being type III RNA pol III promoters, the U6 and H1
promoters share similar regulatory elements, although the H1
promoter is considered to be more compact [16].
The transcription of short hairpin RNAs (shRNAs) from
plasmids using a U6 or H1 promoter gives rise to a 21-22 nt
shRNA where the complementary strands are separated by a short
loop sequence [10,17,18]. The loop sequence is cleaved by Dicer,
an RNase III enzyme, producing the mature, 21-22 nt siRNA.
Another approach in expressing siRNAs has been to use tandem
pol III promoters to drive expression of the sense and antisense
strands of the siRNA, which after being transcribed, will base pair
Academic Editor: Sebastian Fugmann, National Institute on Aging, United States
of America
Received June 18, 2007; Accepted July 23, 2007; Published August 22, 2007
Copyright:  2007 Nassanian et al. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: BL is a Charles E. Culpepper Medical Scholar and is a recipient of the
Burroughs Wellcome Fund Career Development Award. Support from the UCLA
AIDS Institute is acknowledged. AMS is a recipient of an NIH National Research
Service Award (grant 1 F31 AI 61847).
Competing Interests: The authors have declared that no competing interests
exist.
* To whom correspondence should be addressed. E-mail: bleebhl@microbio.
ucla.edu
PLoS ONE | www.plosone.org 1 August 2007 | Issue 8 | e767and form a functional siRNA [11]. Inverted promoter systems that
can drive transcription of the sense and antisense strands from the
same piece of double stranded DNA encoding the cognate siRNA
have also been developed. These systems include those using two
U6 promoters [12], a mouse U6 promoter and human H1
promoter [13], and a human U6 promoter and human H1
promoter [14]. These systems have proven to be effective gene
silencers when transfected into cells and there is some suggestion
that siRNA expression from inverted promoters can lead to
more efficient gene silencing than shRNA from single pol III
promoters [14].
We report here the construction and function of pInv-H1,
a plasmid-based siRNA expression system that uses two inverted
minimal H1 promoters to express siRNAs. The H1 promoter used
here consists only of the core 100 bp that has been previously
shown to contain the full promoter activity [16]. Unique
restriction sites flanking the central siRNA-encoding region were
designed to facilitate downstream cloning of any siRNA sequence.
Importantly, the entire expression cassette was generated through
a ligase chain reaction (LCR) since the essential H1 promoter
elements and the siRNA-encoding region were only about 257 bp
in length. Furthermore, we show that the expression cassette can
be moved into a retroviral expression vector, resulting in stable
efficient expression of the siRNA in transduced cells and reducing
expression of the target protein by greater than 80%. Such an
inverted promoter system also opens the possibility of generating
a random siRNA library. In addition, the flexibility of the
construction of the LCR allows for future ‘‘promoter bashing’’
experiments to further improve upon the efficacy of pol III
promoters.
RESULTS
Construction of the inverted H1 promoter-siRNA
expression construct, pInv-H1
The pInv-H1 construct uses two inverted minimal human H1
promoters to independently transcribe the sense and antisense
strands of the siRNA which will anneal to form a functional siRNA
duplex. Figure 1 illustrates the general strategy used for assembling
this inverted H1 promoter vector. Although the H1 promoter is
,300 bp in length, only four promoter elements lying within
100 bp of 59 flanking sequences have been shown to be essential
for maximal in vitro and in vivo expression, making the H1 promoter
a compact promoter [16]. These four elements include the
octamer motif, the Staf-binding site, the proximal sequence
element (PSE) and the TATA box. Seeing that these four elements
are enough for maximal promoter activity, we used this minimal
H1 promoter in our pInv-H1 construct (Fig. 1A).
The inverted H1 promoter-siRNA expression cassette was
generated through a ligase chain reaction (LCR) in which several
short, overlapping oligonucleotides were annealed and ligated at
a high temperature to form a full-length gene [19]. The expression
cassette was formed through two separate LCR reactions,
generating the LCR-1 and LCR-2 products (Fig. 1B–C). The
LCR-1 product (106 bp) was made by ligating six overlapping
oligonucleotides and contains the sequence of the forward H1
promoter (Fig. 1B). The 59 end of this sequence contains a PstI site
and the 39 end contains an EcoRI site. The LCR-2 product
(151 bp) was generated by ligating eight overlapping oligonucleo-
tides and contains the 19 nt siRNA-encoding sequence and the
inverted H1 promoter sequence (Fig. 1B). The 59 end of this
sequence contains an EcoRI site and the 39 end contains a HindIII
site. Since the LCR method relies on the efficient ligation of
several overlapping oligonucleotides, incompletely synthesized
products often appear as smaller fragments, but the full-length
products, LCR-1 and LCR-2, can always be easily detected
(Fig. 1C). After the LCR-1 and LCR-2 products were in-
dependently assembled, they were individually cut with EcoRI
and then ligated to form the full-length Inv-H1-siRNA cassette
(Fig. 1B). The full-length cassette (257 bp) was then cut with PstI
and HindIII, which flanks the entire inverted siRNA expression
cassette, and cloned into the corresponding PstI/HindIII sites of
the pSUPER vector [10] (Fig. 1D). Although the original pInv-H1
construct was made with the siRNA sequence targeting the
mRNA of DC-SIGN, a C-type lectin receptor highly expressed on
dendritic cells and involved in binding to ICAM-2 [20], ICAM-3
[21], and HIV-1 gp120 [22,23], the oligonucleotides were
designed with EcoRI and BglII sites flanking the siRNA sequence,
allowing for the convenient exchange of siRNA sequences. Thus,
we also generated a pInv-H1 construct capable of giving rise to
a siRNA targeting the p53 mRNA.
pInv-H1 efficiently silences expression of DC-SIGN
and p53
To test the efficiency of pInv-H1, 293T cells were transfected with
pInv-H1 targeting a specific gene and the mRNA levels of the
target gene were monitored by quantitative polymerase chain
reaction (Q-PCR). We first used our construct to silence DC-
SIGN. The pInv-H1-siDC-SIGN construct was co-transfected into
293T cells with an expression plasmid encoding DC-SIGN. A
significant decrease (85% reduction) in DC-SIGN mRNA levels
was observed upon expression of pInv-H1-siDC-SIGN compared
to the non-specific pInv-H1-sip53 control (normalized at 100%)
(Fig. 2A). The same siRNA sequence was expressed from the
pSUPER vector, a construct which gives rise to a short hairpin
RNA (shRNA) previously shown to efficiently silence target genes
[10]. In this experiment, pSUPER-siDC-SIGN expression resulted
in a 60% reduction in DC-SIGN mRNA levels compared to the
non-specific pSUPER-sip53 control (normalized at 100%). This
indicates that when comparing silencing efficiencies between pInv-
H1-siDC-SIGN and that of pSUPER-siDC-SIGN, pInv-H1
silenced expression of DC-SIGN to a greater extent (85% vs.
60% inhibition).
To test the ability of pInv-H1 to silence expression of an
endogenous gene, we used our construct to silence p53 expression
using a previously validated si-p53 sequence [10]. Upon expres-
sion of pInv-H1-sip53, mRNA levels of p53 decreased (80%
reduction) compared to the non-specific pInv-H1-siDC-SIGN
control (Fig. 2B). pSUPER-sip53 expression resulted in a 50%
reduction in p53 mRNA levels compared to the non-specific
pSUPER-siDC-SIGN control (normalized at 100%). As was seen
with the DC-SIGN siRNA, the pInv-H1-sip53 construct silenced
p53 gene expression to a greater extent than pSUPER-sip53.
However, we note that the percentage of p53 inhibition with pInv-
H1 was more variable from experiment to experiment (25–80%
inhibition), and may be related to the differential expression of p53
during different phases of the cell line and/or the variable
transfection efficiency between experiments.
Downregulation of DC-SIGN by retrovirus delivered
siRNA
Two major disadvantages exist with the delivery of siRNA by
plasmid transfection. The first is that with transfections, siRNA
downregulation of the target gene product is transient, limiting the
types of experiments that can be done. Secondly, transfection
efficiency is often inconsistent leading to significant variations in
the level of knockdown. These shortcomings of plasmid transfec-
siRNA and Inverted HI Promoter
PLoS ONE | www.plosone.org 2 August 2007 | Issue 8 | e767Figure 1. Construction of pInv-H1. A. Organization of the inverted H1 promoters and sequence encoding a specific siRNA. The expression cassette
contains essential promoter elements. The EcoRI and BglII sites flank the siRNA sequence and can be used to exchange siRNA cassettes. B. Generation
of the Inv-H1-siRNA cassette by a ligase chain reaction (LCR). The numbers associated with the LCR-1 and LCR-2 products correspond to individual
oligonucleotides that are ligated together. Digesting LCR-1 and LCR-2 with EcoRI allows for ligation and formation of the full-length product that can
be cut with PstI and HindIII and cloned into pSUPER. C. Gel electrophoresis of LCR-1 and LCR-2 products. Ten microliters of the LCR reaction were run
in each lane of a 3% Metaphor agarose gel. The fragments corresponding to 106 bp (LCR-1) and 151 bp (LCR-2) were gel purified. D. Cloning scheme
used to generate pInv-H1. The pSUPER construct and the LCR-derived product were digested with PstI and HindIII and ligated together. The original
full-length H1 promoter driving expression of the shRNA product in pSUPER has now been replaced with the inverted H1 promoter siRNA cassette.
doi:10.1371/journal.pone.0000767.g001
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use of retroviral or lentiviral vectors that stably express siRNAs
[24–30]. We decided to examine stable expression of the DC-
SIGN siRNA using a Murine Leukemia Virus (MLV)-derived
retroviral vector encoding a neomycin phosphotransferase marker
gene.
Raji B cells (a B-cell line) overexpressing DC-SIGN were
transduced with either MLV-Inv-H1-siDC-SIGN or an MLV
virus lacking the siRNA sequence at a multiplicity of infection
(MOI) of 0.1. By using a low MOI, the probability of multiple
integrations per cell is reduced, thus transductants are predicted to
arise from single integration events. Transduced cells were selected
in G418 and expanded. Six weeks post-transduction, we
proceeded to evaluate the ability of our Inv-H1-siDC-SIGN
cassette, likely present in a single copy per cell, to downregulate
DC-SIGN. Figure 3 demonstrates the efficacy of DC-SIGN
knockdown at the protein level. Densitometric measurements
indicated that DC-SIGN protein expression was reduced by more
than 80% in cells transduced with MLV-Inv-H1-siDC-SIGN (lane
3) compared to cells transduced with the parental MLV vector
(lane 2). These results indicate that our inverted H1 promoter
cassette, even at a single copy level per cell, is capable of
maintaining gene silencing 6 weeks after retroviral transduction as
these were stable G418 resistant transductants.
DISCUSSION
In this report, we describe the function of pInv-H1, a vector
system that utilizes two inverted minimal H1 promoters to
independently drive expression of the sense and antisense strands
of a functional duplex siRNA. Although there have been several
reports of convergent or tandem promoter systems that function in
a similar way, there have been no reports to date of such a system
incorporating two minimal H1 promoters. It has been suggested
Figure 2. Quantitative polymerase chain reaction (Q-PCR) detecting gene-specific silencing. A. Silencing of DC-SIGN. Total RNA was isolated from
293T cells co-transfected with pcDNA3-DC-SIGN-AU1 and pInv-H1-siDC-SIGN or pcDNA3-DC-SIGN-AU1 and pInv-H1-sip53 and 250 ng analyzed by
quantitative RT-PCR. The data presented is from one out of three experiments comparing pInv-H1-siDC-SIGN to that of pSUPER-siDC-SIGN, with DC-
SIGN inhibition ranging from 55–85%. Each sample was analyzed in duplicate and standard deviation is shown. B. Silencing of p53. Total RNA was
isolated from 293T cells transfected with pInv-H1-sip53 or pInv-H1-siDC-SIGN and 250 ng analyzed by quantitative PCR. The data presented here is
from one out of four experiments. Each sample was analyzed in duplicate and standard deviation is shown.
doi:10.1371/journal.pone.0000767.g002
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siRNA-encoding sequence may lead to vector instability [13,14].
However, we have shortened the minimal promoter unit from
,300 bp to ,100 bp and introduced different restriction sites
flanking the central siRNA sequence so as to enhance the
asymmetry of the promoter cassette and lessen the instability that
may come from hairpin formation or homologous recombination.
The initial construction of the entire promoter-siRNA cassette
was performed by a ligase chain reaction of multiple oligonucleo-
tides that ranged from 20 nt to 50 nt in length. Once the construct
was made, it was easy to exchange siRNA-encoding sequences by
simply digesting the vector with EcoRI and BglII and ligating in
two annealed oligonucleotides containing the new siRNA-encod-
ing sequence. The shorter oligonucleotides required (45 bp versus
64 bp for the shRNA construct) also makes this vector a more
efficient expression vector for multiple siRNAs. Alternatively, we
also note that oligonucleotides #7, 8 and 12 (Fig. 1B) can be
changed to accommodate any new siRNA sequence; the inverted
siRNA expression cassette with the new siRNA sequence can then
be made entirely by LCR by re-using the rest of the 11
oligonucleotides that have already been made. This underscores
the flexibility of the LCR methodology for generating this minimal
inverted H1 promoter, and suggests that additional control
elements (such as tet responsive elements or loxP stop sequences)
can also be introduced without too much difficulty.
Although the design of pInv-H1 allows for the easy exchange of
siRNA cassettes, there is some restriction on the siRNA sequences
that can be used in this system. For optimal RNA polymerase III
gene expression, purines are required at the 59 ends of newly
initiated RNAs; transcription complexes initiating transcription
with pyrimidine residues are less stable than those starting with
purines [31]. Therefore, the first base of the 19 nt sequence of the
siRNA must be a purine and the last base a pyrimidine for efficient
transcription to take place. The siRNA sequences used here to
target DC-SIGN and p53 both follow this rule. A direct
comparison of the same siRNA sequence produced as a shRNA
from the pSUPER vector and a duplex siRNA from our inverted
H1 promoter vector suggested that our inverted promoter system
is at least as efficient in gene silencing if not more. This may be due
to the lack of additional processing required to produce the
functional siRNA, as has been suggested by others [14].
We also show that this siRNA expression cassette can easily be
shuttled into a retroviral expression system and used to generate
recombinant viruses for more efficient cell transduction. Impor-
tantly, at an MOI of 0.1, which is likely to result in a majority of
single copy transductants, the targeted protein was reduced by
greater than 80%. This suggests that the pInv-H1 siRNA expres-
sion cassette is highly efficient in mediating gene silencing and may
be appropriate for the development of siRNA libraries or siRNA-
knockdown transgenic animals. Although inverted or convergent
promoter systems for driving siRNA expression have been
reported, we show here the application of this system in a retroviral
delivery context. By controlling the MOI, we demonstrate that this
inverted promoter expression cassette, even at a single copy level,
can effectively silence target gene expression.
In summary, we show the generation of our inverted H1
promoter cassette by the use of a ligase chain reaction. The use of
the LCR allows for the flexibility of regenerating the entire
promoter cassette by substituting a few oligonucleotides. This
allows for the potential of ‘‘promoter bashing’’ experiments or
including inducible control elements to further expand the
capability of our siRNA expression cassette.
MATERIALS AND METHODS
Construction of pInv-H1
To construct pInv-H1-siDC-SIGN, overlapping oligonucleotides
were synthesized (MWG Biotechnology; HPLC-purified) and
resuspended to 100 mM in water:
InvH1.siDC-S.1: tgcaatCTGCAGATTTGCATgTCGCTAT-
GTGTTCTGGGAAATCACC
InvH1.siDC-S.2: ATAAACGTGAAATgtctttggatttgggaatcTT-
ATAAgt
InvH1.siDC-S.3: tctgtatgaATTcactcaaa
InvH1.siDC-S.4: AGCGAcATGCAAATCTGCAGattgca
InvH1.siDC-S.5: caaagacATTTCACGTTTATGGTGATTT-
CCCAGAACA CAT
InvH1.siDC-S.6: tttgagtgAATtcatacagaacTTATAAgattcccaaatc
InvH1.siDC-S.7: tctgtatgaATTcactcaaaaacAATCCAGGCAA-
GACGCG
InvH1.siDC-S.8: ATgtttttcagtAGATCTatacagaacTTATAA-
gattccc
InvH1.siDC-S.9: aaatccaaagacATTTCACGTTTATGGTG-
ATTTCCAGAA
InvH1.siDC-S.10: CACATAGCGAcATGCAAATAAGCTT-
cggctc
InvH1.siDC-S.11: tttgagtgAATtcatacaga
InvH1.siDC-S.12: atAGATCTactgaaaaacATCGCGTCTTG-
CCTGGATTgtt
InvH1.siDC-S.13: CGTGAAATgtctttggatttgggaatcTTATAA-
gttctgt
InvH1.siDC-S.14: gagccgAAGCTTATTTGCATgTCGCTA-
TGTGTTCTGGGAAATCACCATAAA
The siDC-SIGN sequence is indicated in InvH1.siDC-S.7 and
InvH1.siDC-S.8 in bold. Oligonucleotides 2–5 and 8–13 were 59-
end phosphorylated overnight with T4 polynucleotide kinase (New
England Biolabs). Phosphorylated oligonucleotides 2–5 were
combined with 6 ml InvH1.siDC-S.1 and 6 ml InvH1.siDC-S.6
(to form LCR-1 product) and phosphorylated oligonucleotides 8–
13 were combined with 6 ml InvH1.siDC-S.7 and 6 ml In-
vH1.siDC-S.14 (to form LCR-2 product) in a ligase chain reaction
containing 8 U Pfu ligase (Stratagene) and 5 ml1 0 6 Pfu ligase
Figure 3. Efficient suppression of DC-SIGN in retrovirally transduced
Raji B-DC-SIGN cells. Western blot analysis of DC-SIGN expression in
Raji B-DC-SIGN stable cells (lane 1), Raji B-DC-SIGN cells transduced at
MOI=0.1 with an empty retroviral vector (lane 2) or with a retroviral
vector encoding the Inv-H1-siDC-SIGN cassette (lane 3). To ensure equal
loading of protein, the blot was washed and re-probed for actin.
doi:10.1371/journal.pone.0000767.g003
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incubation of 95uC for 1 min, 40 cycles of 55uC for 1 min 30 s,
70uC for 1 min 30 s, 95uC for 30 s, with an additional incubation
at 55uC for 2 min and 70uC for 2 min on the final cycle. The LCR
reactions were electrophoresed through a 3% Metaphor agarose
gel. Fragments corresponding to LCR-1 and LCR-2 were purified
using Quantum Prep Freeze 9N Squeeze DNA Gel Extraction
Spin Columns (BioRad Laboratories), ethanol precipitated, and
digested with EcoRI. The two products were gel purified as
described and ligated. The ligation product was digested with PstI
and HindIII and ligated into PstI/HindIII digested pSUPER. To
generate pInv-H1-sip53, the pInv-H1-siDC-SIGN was digested
with EcoRI and BglII and ligated with the annealed, phosphory-
lated oligonucleotides corresponding to the sip53 sequence (in
bold): forward: AATTCACTCAAAAACGACTCCAGTGGTA-
ATCTACGTT TTTCAGTA; reverse: GATCTACTGAAAA-
ACGTAGATTACCACTGGAGTCGTTTTTGAGTG.
Cell culture and transfection
293T cells were cultured in DMEM (Gibco) containing 10% FBS
supplemented with 1% penicillin-streptomycin (Gibco). Cells were
cultured in 6-well plates and transfected by calcium phosphate. A
total of 8 mg DNA was transfected into each well. For DC-SIGN
gene silencing experiments, cells were co-transfected with 2 mg
pcDNA3-DC-SIGN-AU1 and 2 mg of pSUPER-sip53, pSUPER-
siDC-SIGN, pInv-H1-siDC-SIGN, or pInv-H1-sip53. An addi-
tional 4 mg of pENTR (Invitrogen), a promoter-less vector used as
filler DNA, was also transfected. For analyzing p53 silencing, cells
were transfected with 6 mg pSUPER-sip53, pSUPER-siDC-SIGN,
pInv-H1-siDC-SIGN, or pInv-H1-sip53 and 2 mg of pENTR.
RNA analysis
Three days after transfection, total RNA was isolated from cells
using Trizol reagent (Invitrogen) according to the manufacturer’s
recommendations. For each condition, 250 ng of total RNA was
analyzed in duplicate by quantitative real-time PCR using
QuantiTect RT-PCR reagents (Qiagen). Briefly, RNA was added
to QuantiTect probe mix, 3 mM forward and reverse primers,
5 mM probe, 50 mM MgSO4, QuantiTect RT mix, and Rnase-
free water. A reverse transcription one-step PCR protocol was
carried out as follows using DNA Engine Opticon: 30 min 15 sec
at 50uC, 10 min at 95uC, followed by 15 sec at 95uC and 1 min at
60uC for 45 cycles. Gene-specific primers and probes for DC-
SIGN and p53 were used to quantitate RNA levels. RNA from
each sample was also analyzed for actin RNA copies to use as
a means for normalization. The primers (MWG Biotechnology)
and probes (PE Applied Biosystems) used were as follows: DC-
SIGN, 59-GCTGAGAGGCCTTGGATTCC-39 and 59-AGAG-
CGTGA AGGAGAGGAGTTG-39, (probe, 59-FAM-ACCATG-
GCCAAGACACAC CCTGCTA-TAMRA-39); p53, 59-CTGC-
TCAGATAGCGATGGTCTG-39 and 59-TTGTAGTGGATG-
GTGGTACAGTCA-39, (probe, 59-FAM-CCCC TCCTCAGC-
ATCTTATCCGAGTGG-TAMRA-39); actin, 59-GCATGGGT
CAGAAGGATTCCT-39 and 59-TGCCAGATTTTCTCCAT-
GTC-39, (probe, 59-FAM-TGAAGTACCCCATCGAGCACGG-
CAT-TAMRA-39).
Construction and Transduction of Retroviral Vector
Expressing pInv-H1-siDC-SIGN cassette
The Inv-H1-siDC-SIGN cassette was subcloned into the MLV
derived retroviral vector pLIB (Clontech). First, the vector was
modified by cloning cDNA derived from pCMMP.GFP/Neo (gift
from R. Mulligan) encoding a green fluorescent protein (GFP)-
neomycin phosphotransferase gene fusion into the SalI and NotI
sites of the pLIB MCS. The Inv-H1-siDC-SIGN cassette was
subcloned from the pSUPER vector into the NotI and ClaI sites of
the MCS of the modified pLIB vector. The resulting plasmid was
co-transfected into 293 cells with MLV gag/pol and VSV-G
expression plasmids pMD.gagpol and pMD.G respectively. The
resulting viral particles were harvested from the media at 48 and
72 hrs, sterile filtered (0.45 mm) and used to transduce 293 or Raji
B cells in the presence of 8 mg/ml polybrene. FACS analysis was
conducted 72 hrs post-transduction to calculate viral titer based on
the percent GFP positive cells. Viral titers of 1610
4 infectious
units/ml were obtained.
DC-SIGN overexpressing Raji B cells were transduced using
a multiplicity of infection (MOI) of 0.1 in the presence of 8 mg/ml
polybrene. Cells were placed in 600 mg/ml G418 48 hrs post-
transduction to select for transductants.
Western Blot Analysis
Six weeks post-transduction, Raji B cells were lysed and total
cellular protein was extracted. Protein concentration was de-
termined using the BioRad Protein Assay reagent (Bio-Rad
Laboratories). Equal amounts of lysate (35 mg) were resolved on
10% SDS-PAGE and transferred to polyvinylidene fluoride
(PVDF) membrane. DC-SIGN was detected using rabbit anti-
DC-SIGN antibody and ImmunoPure HRP-conjugated donkey
anti-rabbit secondary antibody (Pierce Biotechnology). The blot
was developed using ECL Plus (Amersham Biosciences). The blot
was washed several times with PBS/0.2% Tween-20 buffer and re-
probed with anti-actin HRP (Santa Cruz Biotechnology).
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